On this page

Tiguvon Pour-On Cattle Insecticide

Fenthion

Veterinary NADA Approved 234 adverse event reports

Overview

Source: Animal Drugs @ FDA
Proprietary name
Tiguvon Pour-On Cattle Insecticide
Active ingredient
Fenthion
Application type
NADA
Sponsor
Elanco US Inc.
Applications on record
1
First published
August 5, 2020

Adverse event reports

Source: openFDA VeDDRA
234
Reports mentioning this ingredient
March 17, 1987 – January 21, 2011
1
Classified serious
per reporter assessment
31
Lack of expected efficacy
resistance signal
6
Human operator exposure
needle-stick or splash
Not a risk measure. Veterinary adverse event reports are influenced by how many animals are treated, reporting practice and product age. Reports do not establish that the product caused the event, and a single report can cover an entire herd or flock. Attribution here is by active ingredient because the source dataset redacts brand names.

Attributed by active ingredient “FENTHION”. Green Book ingredient names and VeDDRA ingredient names do not always agree exactly, so attribution is approximate and labelled as such.

Reported reactions

Source: openFDA VeDDRA

Clinical signs coded in the VICH VeDDRA four-level hierarchy, most frequent first.

Reaction terms reported for this ingredient, by report count.
Reaction (VeDDRA term) Reports Relative frequency
Death 41
Vomiting 25
Hypersalivation 24
INEFFECTIVE, GRUBS 24
Depression 22
Trembling 22
Lack of efficacy (ectoparasite) - lice 20
Anorexia 18
Diarrhoea 17
Vials, Leaking 17
Skin lesion NOS 15
Containers, Abnormal 15
Alopecia NOS 14
Ataxia 13
Weakness 10
Lack of efficacy (ectoparasite) - flea 9
Unclassifiable adverse event 8
Recumbency 8
Bloody diarrhoea 7
Accidental exposure 6

Species affected

Source: openFDA VeDDRA
Dog 95 Cattle 75 Cat 10 Human 7 Eagle 1 Other 1

Regulatory context

New Animal Drug Application (NADA). A pioneer approval evaluated for target animal safety, therapeutic effectiveness, manufacturing controls and — for food-producing species — human food safety including residue depletion.

Extra-label use in food-producing animals is governed by the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) and 21 CFR Part 530. It requires a valid veterinarian-client-patient relationship and is prohibited outright for certain drug classes. Withdrawal times are determined by FARAD, not by this index.

Sources for this page

Animal Drugs @ FDA FDA CVM Applications, sponsor, status, withdrawal
Animal & Veterinary Events FDA CVM VeDDRA adverse event aggregates by active ingredient